mHealth application areas and technology combinations (evidence up to August 2015)

Added July 1, 2020

Citation: Abaza H, Marschollek M. mHealth application areas and technology combinations: a comparison of literature from high and low/middle income countries. Methods of information in medicine. 2017 Jan;56(S 01):e105-22.

What is this? The COVID-19 pandemic is placing a strain on healthcare systems, workers and patients. Existing research on mobile Health (mHealth, healthcare delivered via mobile devices and wireless communication) strategies might provide useful information to ease this.

In this literature review, the authors searched for studies that reviewed mHealth applications, comparing use and type of application between high-income countries and low- and middle-income countries. They restricted their searches to articles published in English and did the search in August 2015. They included 255 articles.

What was found: The two most popular application areas for mHealth were (a) health promotion and raising awareness and (b) health monitoring and surveillance.

The most commonly address medical condition was diabetes, but it was not adequately targeted in low- and middle-income countries, along with other non-communicable diseases.

The most popular mHealth technology types were SMS messages and smartphone/PDA apps.

The effects of the reviewed mHealth applications in low- and middle-income countries are uncertain.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.